CIK 0001599298
- Large accelerated filer
Summit Therapeutics Inc.
Sign in to watch- Ticker
- SMMT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 371979717
- Phone
- +1 305-203-2034
- Business address
- 601 BRICKELL KEY DRIVE, SUITE 1000, MIAMI, FL, 33131
- Former names
- Summit Therapeutics plc, Summit Corp plc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-25 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2022-01-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-01-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +42,553 | $1.13 | $48K | 67,553 |
| 2021-11-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2021-11-03 | Gayko Urte Director | Grant or award · Stock Option (right to buy) | +4,041 | 204,041 |
Page 1 of 1 · 5 trades